2,099 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
PFE Pfizer, Inc. $43.01 $252.13B Buy
Article Searches
Breakout Alert: Healthcare Stocks Are Surging https://seekingalpha.com/article/4207877-breakout-alert-healthcare-stocks-surging?source=feed_sector_healthcare Sep 24, 2018 - Stock markets have rallied strongly this year, with all three centralized stock benchmarks hitting recent records.But the healthcare sector has been a standout in this environment, and the recent brea
Big Pharma Levers Up As Deal Activity Settles Down https://seekingalpha.com/article/4207771-big-pharma-levers-deal-activity-settles?source=feed_sector_healthcare Sep 23, 2018 - Pfizer and AbbVie registered debt offerings with the SEC for $5bn and $6bn respectively, while Bristol-Myers sits tight on a recent shelf offering.AbbVie reigns as debt queen, looking to refinance the
Dow 30 Stock Roundup: JPMorgan Ups Dividend, Disney's ESPN+ Hits 1M Paid Subscribers http://www.zacks.com/stock/news/324194/dow-30-stock-roundup-jpmorgan-ups-dividend-disneys-espn%2B-hits-1m-paid-subscribers?cid=CS-ZC-FT-324194 Sep 21, 2018 - The index made strong gains this week as investors shrugged off trade tensions.
Companies Stockpile Drugs, Chocolate as They Brace for 'Hard' Brexit https://www.wsj.com/articles/companies-brexit-challenge-preparing-for-the-unknown-1537435801?mod=pls_whats_news_us_business_f Sep 20, 2018 - Some of the world’s biggest companies are drawing up plans for the unplannable: a March divorce between Britain and the European Union, in which even some basic parameters have yet to be hammered out.
Arvinas Holding Prepares Terms For $100 Million IPO https://seekingalpha.com/article/4207415-arvinas-holding-prepares-terms-100-million-ipo?source=feed_tag_ipo_analysis Sep 20, 2018 - Arvinas Holding aims to sell $100 million of its common stock in a U.S. IPO.The firm is advancing a pipeline of drug candidates for the treatment of various cancers.Although still a very early stage c
Eli Lilly Prices Animal Health Unit IPO at $24 Per Share http://www.zacks.com/stock/news/324124/eli-lilly-prices-animal-health-unit-ipo-at-%2424-per-share?cid=CS-ZC-FT-324124 Sep 20, 2018 - Lilly (LLY) prices Elanco IPO at $24 per share which is above the expected range of $20-$23 per share.
J&J Files NDA for Erdafitinib in Urothelial Cancer Indication http://www.zacks.com/stock/news/323898/jj-files-nda-for-erdafitinib-in-urothelial-cancer-indication?cid=CS-ZC-FT-323898 Sep 19, 2018 - Johnson & Johnson (JNJ) submits regulatory application to the FDA seeking approval of pan-FGFR inhibitor, erdafitinib, for the treatment of metastatic urothelial cancer, a type of bladder cancer.
Your Daily Pharma Scoop: Alnylam Regains, Karyopharm Positive, Teva Approved https://seekingalpha.com/article/4206899-daily-pharma-scoop-alnylam-regains-karyopharm-positive-teva-approved?source=feed_sector_healthcare Sep 18, 2018 - Alnylam had an eventful week.Karyopharm reports positive Phase 2 data.Teva’s migraine drug is approved.
Can Pfizer (PFE) Bank on Bavencio for Long-Term Growth? http://www.zacks.com/stock/news/323475/can-pfizer-pfe-bank-on-bavencio-for-long-term-growth?cid=CS-ZC-FT-323475 Sep 18, 2018 - Pfizer's (PFE) latest anti-PD-L1 immunotherapy, Bavencio, is being touted as a significant long-term top-line driver for the company.
Glaxo Seeks EU Approval for Two-Drug Regimen in First-Line HIV http://www.zacks.com/stock/news/323451/glaxo-seeks-eu-approval-for-two-drug-regimen-in-first-line-hiv?cid=CS-ZC-FT-323451 Sep 17, 2018 - Glaxo (GSK) submits a regulatory application in the EU for a single-tablet, two-drug regimen of dolutegravir and lamivudine for the first-line treatment of HIV-1 infection.

Pages: 123456...210

Page 1>

Related Companies

Name Exchange Price Mkt Cap
NVS Novartis AG NYSE $85.13 $197.65B
MRK Merck & Company, Inc. NYSE $70.42 $187.28B
ABBV AbbVie Inc. NYSE $95.37 $144.42B
JNJ Johnson & Johnson NYSE $139.96 $375.48B
ABT Abbott Laboratories NYSE $67.67 $118.71B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Pfizer